Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.1%
    Check dated 2025-05-01T06:06:58.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the study on Pembrolizumab for metastatic Non Small Cell Lung Cancer, with the addition of collaborators and a new revision number. Key details about the study's design and eligibility criteria have been removed, which may impact the understanding of the study's scope and requirements.
    Difference
    50%
    Check dated 2025-04-16T16:48:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 24, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T11:30:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:49:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:11:23.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T14:36:25.000Z thumbnail image

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.